SCHEMBL629408

SCHEMBL629408

CC(=O)Nc1nnc(NC(C)=O)s1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.62
CA2 P00918 3/20 0.62
CA9 Q16790 3/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
CA12 O43570 2/20 0.62
CA3 P07451 2/20 0.62
CA4 P22748 2/20 0.62
CA6 P23280 2/20 0.62
CA5A P35218 2/20 0.62
CA7 P43166 2/20 0.62
CA13 Q8N1Q1 2/20 0.62
CA14 Q9ULX7 2/20 0.62
CA5B Q9Y2D0 2/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
CA11 O75493 1/20 0.62
THRB P10828 1/20 0.62
BLM P54132 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
GLS O94925 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2629359 0.86 SMN1; SMN2 (0.65) CA1CA2CA9SMN1; SMN2CA12
SCHEMBL9740903 0.86 SMN1; SMN2 (0.55) CA1CA2CA9SMN1; SMN2CA12
SCHEMBL15315907 0.85 SMN1; SMN2 (0.50) CA1CA2CA9SMN1; SMN2CA12
SCHEMBL10995810 0.84 CA1 (0.58) CA1CA2CA9SMN1; SMN2CA12
SCHEMBL8246439 0.84 SMN1; SMN2 (0.53) CA1CA2CA9SMN1; SMN2CA12
SCHEMBL10878301 0.83 SMN1; SMN2 (0.54) CA1CA2CA9SMN1; SMN2CA12
SCHEMBL11884256 0.81 SMN1; SMN2 (0.50) CA1CA2CA9SMN1; SMN2CA12
SCHEMBL8779354 0.81 RAB9A (0.59) CA1CA2CA9SMN1; SMN2CA12
SCHEMBL13896387 0.81 SMN1; SMN2 (0.54) CA1CA2CA9SMN1; SMN2CA12
SCHEMBL5629418 0.81 RAB9A (0.68) SMN1; SMN2MEN1KMT2ATDP1GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066749-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2021-07-20 US claimed
US-20200173034-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-06-04 US claimed
US-10604850-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-03-31 US claimed
US-20180127882-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2018-05-10 US claimed
WO-2016190865-A1 CORROSION INHIBITION OF HCL TREATMENT FLUIDS WITH ENVIRONMENTALLY COMPATIBLE SOLVENT HALLIBURTON ENERGY SERVICES, INC. (US) 2016-12-01 WO claimed
EP-2419549-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS Halliburton Energy Services, Inc. (US) 2012-02-22 EP claimed
US-7994099-B2 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods HALIBURTON ENERGY SERVICES, INC. (US) 2011-08-09 US claimed
WO-2010119235-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2010-10-21 WO claimed
US-20100261623-A1 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods HALLIBURTON ENERGY SERVICES, INC. 2010-10-14 US claimed
US-11066749-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2021-07-20 US disclosed
US-20200173034-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-06-04 US disclosed
US-10604850-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-03-31 US disclosed
US-20180127882-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2018-05-10 US disclosed
WO-2016190865-A1 CORROSION INHIBITION OF HCL TREATMENT FLUIDS WITH ENVIRONMENTALLY COMPATIBLE SOLVENT HALLIBURTON ENERGY SERVICES, INC. (US) 2016-12-01 WO disclosed
EP-2419549-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS Halliburton Energy Services, Inc. (US) 2012-02-22 EP disclosed
US-7994099-B2 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods HALIBURTON ENERGY SERVICES, INC. (US) 2011-08-09 US disclosed
WO-2010119235-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2010-10-21 WO disclosed
US-20100261623-A1 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods HALLIBURTON ENERGY SERVICES, INC. 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261623-A1 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods MUC1, CA1, MGMT CA1 2/4885CA2 115/4885CA9 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.